Nonalcoholic fatty liver disease (NAFLD), a form of chronic that occurs in individuals with no significant alcohol abuse, has become an increasing concern for global health. NAFLD is defined as the presence lipid deposits hepatocytes and it ranges from hepatic steatosis (fatty liver) to steatohepatitis. Emerging data both preclinical studies clinical trials suggest peroxisome proliferator-activ...

conclusions synbiotic supplementation may improve lipid profile and body composition in patients with nafld and might be useful in prevention of the disease progression. methods eighty patients with nafld participated in this randomized, double-blind, placebo-controlled clinical trial (from march to july 2014) in iran. based on ast and alt as main variables of the study, 34 patients were requir...

The increasing prevalence of obesity, insulin resistance, and the metabolic syndrome has significant implications for the future of chronic liver disease. The resultant increase in the number of patients with nonalcoholic fatty liver disease (NAFLD) is expected to translate into increased numbers of patients with end-stage liver disease (cirrhosis), liver failure, and hepatocellular carcinoma. ...

AIM OF THE STUDY Studying the correlation between elements of metabolic syndrome and histological changes of the liver in nonalcoholic fatty liver disease. PATIENTS AND METHODS Thirty-nine patients with nonalcoholic fatty liver disease were included in our study. Inclusion criteria were: presence of liver steatosis on ultrasound in patients with waist circumference over 94 cm in men and over ...

CONTEXT Nonalcoholic fatty liver disease encompasses a spectrum of histopathological changes that range from simple steatosis to nonalcoholic steatohepatitis. Works suggest that iron (Fe) deposits in the liver are involved in the physiopathology of nonalcoholic steatohepatitis. OBJECTIVE The aim of this study was to determine the prevalence of simple steatosis and nonalcoholic steatohepatitis...